Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Ventripoint Issues Option Grants
View:
Post by yukon61 on Jan 13, 2021 5:20pm

Ventripoint Issues Option Grants

Ventripoint Issues Option Grants

(via TheNewswire)



Toronto, Ontario – TheNewswire - January 13, 2021– Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”), (TSXV:VPT) & (OTC:VPTDF) announces the granting 100,000 options to each of the Directors of the Corporation at an exercise price of $0.10 for a term of 10 years with 25% vesting immediately and 25% vesting each year for 3 years thereafter. In addition, 1,410,000 option have been granted to employees and consultants at an exercise price of $0.10 for term from 1 to 10 years, with variable vesting schedules. The Corporation now has 1,542,435 options available for future grants under the Stock Option Plan as approved by shareholders at the last Special and Annual General Meeting on December 14, 2020.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments.  In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe and Canada.  

For further information, please contact:

Mr. Peter Weichler, Director

Email: peter@weichler.ca

Or

Mr. Clay Chase

Email: cc@sdthc.com

Phone: 858-456-7300

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Copyright (c) 2021 TheNewswire - All rights reserved.

Comment by Pandora on Jan 13, 2021 7:23pm
Also just posted:   Ventripoint amends articles for registered office   2021-01-13 19:08 ET - News Release   Dr. George Adams reports VENTRIPOINT ANNOUNCES FILING OF ARTICLES OF AMENDMENT Ventripoint Diagnostics Ltd. has filed articles of amendment in accordance with the Canada Business Corporations Act to change the province in which the registered office of the ...more  
Comment by Sunvalley on Jan 14, 2021 6:35am
Good move George. Nothing like a piece of the pie to keep the troops engaged and all pulling in the same direction. The fairly long  vesting period also makes good sense in my opinion in that you just cannot "take the money and run" in the near term.  
Comment by SunsetGrill on Jan 14, 2021 10:22am
Well LMFAO - if you again notice in the press release (like all oother over the past ten years) there was no money to run with.  THants what kills me here - a press release that says nothing in regard to a sale and no mention of money at all (just more research into fluffy and rover). The company needs income and fast  BTW it looks like the run to 13 whole cents is over - could not get ...more  
Comment by Gdangit on Jan 14, 2021 10:55am
I agree 110%. This stock is only built on high hopes and speculations. There will never be any actual sales or facts in my opinion. That was its time of the year. Quick money grab to take a little skim from the milk. I'd say 9 cents will be its full time support level
Comment by Sunvalley on Jan 14, 2021 11:45am
My opinion differs greatly from your Gdangit. Do you own any of this stock?
Comment by Gdangit on Jan 14, 2021 2:40pm
to answer your question SunValley yes I own a pretty nice chunk of this stock. I bought over 100k shares at 9 cents. Now I realize we are all going to stay bullish especially considering our share price execution and fill. I've been researching this company for quite some time and I'd have to say either you have to be a believer in any company to make a go. I do agree with old dog to stay ...more  
Comment by Sunvalley on Jan 14, 2021 3:27pm
Gdangit , thank you for your answer. While  I can understand your frustration ,  as I also have been a holder for quite some time , I also believe that this is a  potential ground breaking situation with unlimited possibilities IF they can get their act together and get things rolling. With Covid now in the picture for the foreseeable future we now have a added dimension for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities